aflorithmic labs
- Home
- aflorithmic labs
Public
Opening a new frontier in treating Parkinson’s disease
- Review
- November 11, 2022
Is this the most hated company on the ASX?
- Review
- August 16, 2019
Latest Articles
UNITH’s investment in generative AI sees 100% growth, driven by AudioStack’s synthetic audio and voice cloning
Artificial intelligence company UNITH (ASX: UNT) has witnessed a 100% increase in the value of its investment in AudioStack, a testament to its foresight in the realm of generative AI with UNITH’s 9.7% rising to $3.9m, up from $2m in just 8 months. AudioStack, formerly known as Aflorithmic Labs, recently concluded a significant pre-Series A
Read MorePublic
Invest in good investors, UNITH delivers big jump in value behind tech of its digital humans
For many investors, backing proven stock pickers can deliver mammoth returns. Just look at the Berkshire Hathaway investors that assign Warren Buffett to invest for them. But when it comes to artificial intelligence, younger heads may be the ones to follow as evidenced by AI company UNITH (ASX: UNT) which develops digital humans and reported
Read MorePublic
Crowd Media strengthens balance sheet as next AI milestone looms
As long time leaders in the influencer and social media spaces, eCommence company Crowd Media (ASX: CM8) have had much of their digital market invaded through the pandemic, but emerged in a better than ever position thanks to prude capital management and their newly formed artificial intelligence alliance. Key to Crowd’s financial improvement has been
Read MorePublic
Crowd Media adds voice cloning for immersive celebrity experiences in AI deal
Facetime conversations with your favourite celebrity could soon be a reality with eCommerce and artificial intelligence company Crowd Media (ASX: CM8) securing a vital partnership that will provide access to the best-in-class voice cloning technology. The partnership is with Europe-based synthetic media company Aflorithmic Labs (AFLR) and has been entered into alongside a strategic investment
Read MorePublic
